American Elements
Platinum Oxide Tablets
PtO2
1314-15-4
Product
Product Code
Order or Specifications
99% Platinum Oxide Tablets
PT-OX-02-TBS
 Contact American Elements
99.9% Platinum Oxide Tablets
PT-OX-03-TBS
 Contact American Elements
99.99% Platinum Oxide Tablets
PT-OX-04-TBS
 Contact American Elements
99.999% Platinum Oxide Tablets
PT-OX-05-TBS
 Contact American Elements
American Elements specializes in producing high purity unifrom shaped Platinum Oxide Tablets with the highest possible density and smallest possible average grain sizes for use in Chemical Vapor Deposition (CVD) and Physical Vapor Deposition (PVD) processes including Thermal and Electron Beam (E-Beam) Evaporation, Low Temperature Organic Evaporation, Atomic Layer Deposition (ALD), Metallic-Organic and Chemical Vapor Deposition (MOCVD). Our standard Tablet sizes average in the range of 3 mm, 4 -5 mm, 10 - 50 mm, 1/8" and 1/4". We can also provide Tablets outside this range. We also produce Platinum Oxide as pellets, pieces, powder, and sputtering target. Oxide compounds are not conductive to electricity. See research below. Other shapes are available by request.

Platinum is a Block D, Group 10, Period 6 element. The electronic configuration is Xe] 4f14 5d9 6s1. In its elemental form platinum's CAS number is 7439-88-5. The platinum atom has a radius of 137.3.pm and it's Van der Waals radius is 172.pm.

Formula CAS No. Appearance Molecular Weight
PtO2 1314-15-4 Brown Powder 227.09
PRODUCT CATALOG Submicron & Nanopowder Tolling Ultra High Purity Sputtering Target Crystal Growth Rod, Plate, Powder, etc.
© 2001-2007. American Elements is a U.S. Registered Trademark. All rights reserved.
This website and all pages, designs, concepts, logos, and color schemes herein are
the copyrighted proprietary rights and intellectual property of American Elements.

 

Recent Research & Development for Platinum

  • Matrix Metalloproteinase-9 May Play a Role in Recanalization and Recurrence after Therapeutic Embolization of Aneurysms or Arteries. J Vasc Interv Radiol. 2007 Oct;18(10):1271-1279.

  • Combination therapy with pegylated liposomal doxorubicin and carboplatin in gynecologic malignancies: A prospective phase II study of the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and Kommission Uterus (AGO-K-Ut). Gynecol Oncol. 2007 Oct 1; [Epub ahead of print]

  • Phase II clinical study of gemcitabine in the treatment of patients with advanced nasopharyngeal carcinoma after the failure of platinum-based chemotherapy. Cancer Chemother Pharmacol. 2008 Jan;61(1):33-38. Epub 2007 Mar 20.

  • Endovascular treatment of basilar and ICA termination aneurysms: effects of the use of HydroCoils on treatment stability in a subgroup of patients prone to a higher recurrence rate. Neuroradiology. 2007 Oct 2; [Epub ahead of print]

  • Synthesis, structures and properties of a new series of platinum-diimine-dithiolate complexes. Dalton Trans. 2007 Oct 21;(39):4446-56. Epub 2007 Aug 9.

  • The first example of a Pt[dot dot dot]Pt interaction in platinum(ii) complexes bearing bulky tri-tert-butyl-2,2':6',2''-terpyridine pendants via conformational control of the calix[4]arene moiety. Dalton Trans. 2007 Oct 21;(39):4386-9. Epub 2007 Sep 6.

  • Irinotecan-Cisplatin Therapy for Patients with Extensive-Stage Small Cell Lung Cancer: Use Patterns among American Medical Oncologists 2000-2006. J Thorac Oncol. 2007 Oct;2(10):953-956.

  • Comparison of Docetaxel- and Vinca Alkaloid-Based Chemotherapy in the First-line Treatment of Advanced Non-small Cell Lung Cancer: A Meta-analysis of Seven Randomized Clinical Trials. J Thorac Oncol. 2007 Oct;2(10):939-946.

  • Docetaxel and Exisulind in Previously Treated Non-small Cell Lung Cancer (NSCLC) Patients: A Multicenter, Phase II Clinical Trial. J Thorac Oncol. 2007 Oct;2(10):933-938.

  • ERCC1 mRNA Expression Is Not Associated with Response and Survival after Platinum-Based Chemotherapy Regimens in Advanced Non-Small Cell Lung Cancer. J Thorac Oncol. 2007 Oct;2(10):902-906

  • Changes in pelvic and systemic platinum concentrations during negative-balance isolated pelvic perfusion: correlation between platinum concentration and method of administration in a pig model.
    J Cancer Res Clin Oncol. 2007 Jan 24; [Epub ahead of print]

  • Revision stapes surgery.
    Adv Otorhinolaryngol. 2007;65:314-9.

  • Revision stapes surgery - retrospective analysis of surgical findings in a series of 21 otosclerosis patients.
    Adv Otorhinolaryngol. 2007;65:273-7.

  • The crimping problem in stapes surgery.
    Adv Otorhinolaryngol. 2007;65:202-5.

  • Autogenic and xenogenic materials in stapes surgery - retrospective analysis of 350 cases.
    Adv Otorhinolaryngol. 2007;65:179-83.

  • Evolution of Stapedectomy Prostheses over Time.
    Adv Otorhinolaryngol. 2007;65:174-8.

  • The influence of the footplate-perilymph interface on postoperative bone conduction.
    Adv Otorhinolaryngol. 2007;65:155-7.

  • Photoreversible multiple additions of hydrogen to a highly unsaturated platinum-rhenium cluster complex.
    J Am Chem Soc. 2007 Jan 31;129(4):986-1000.

  • A mediator-free amperometric hydrogen peroxide biosensor based on HRP immobilized on a nano-Au/poly 2,6-pyridinediamine-coated electrode.
    Bioprocess Biosyst Eng. 2007 Jan 23; [Epub ahead of print]

  • Independent prognostic significance of cell cycle regulator proteins p16(INK4a) and pRb in advanced-stage ovarian carcinoma including optimally debulked patients: a translational research subprotocol of a randomised study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
    Br J Cancer. 2007 Jan 29;96(2):306-13.

 

 

 

 

American Elements Products can also be sourced at these sites:
 
 
 
electronics-ee.com